Evidence map›Paper›PMID 31379993›Full record

ArticleAvicenna journal of medical biotechnology

MIG1 Glucose Repression in Metabolic Processes of

Iraj Alipourfard, Nelly Datukishvili, Salar Bakhtiyari, Karimeh Haghani, Laura Di Renzo, Renata Costa de Miranda, David Mikeladze

Open access · greenAbstract read
In one paragraph

Article in Avicenna journal of medical biotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Iraj AlipourfardInstitute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia.
Nelly DatukishviliInstitute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia.
Salar BakhtiyariDepartment of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Karimeh HaghaniDepartment of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Laura Di RenzoSection of Clinical Nutrition and Nutrigenomics, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Renata Costa de MirandaFaculty of Applied Medical-Surgical Sciences, University of Rome Tor Vergata, Rome, Italy.
David MikeladzeInstitute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia.
Ilam University · IRCoordenação de Aperfeicoamento de Pessoal de Nível Superior · BRUniversity of Rome Tor Vergata · ITUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough

methodsTo find the impact of

resultsResults suggest that Δ

conclusionThe constructed strain has more efficient growth in aerobic cultivations and it can be a potential host for biotechnological recombinant yields and industrial interests.

Indexed as

Homologous recombinationMetabolic pathwaysSaccharomyces cerevisiaeYeasts

Identifiers

PMID31379993
PMCPMC6626512
OpenAlexW2964643197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.